Stock Comparison

HQL vs JPM

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricHQLTekla Life Sciences InvestorsJPMJPMorgan Chase & Co.
Market Cap$491.34M$833.83B
Current Price$16.60$309.26
P/E Ratio21.0115.66
Revenue Growth 1Y23.6%14.6%
Net Margin56.8%21.6%
ROE5.6%17.4%
ROIC-1%5.4%
Debt/Equity2.18
FCF Yield
Dividend Yield1.7%
Loading chart...

HQL vs JPM: Key Questions Answered

Which is the cheapest stock: HQL or JPM?

Based on P/E ratio, JPMorgan Chase & Co. (JPM) is the cheapest at 15.7x earnings. Tekla Life Sciences Investors (HQL) is the most expensive at 21.0x. A lower P/E can indicate better value, but always consider growth rates too.

Which stock is growing the fastest: HQL or JPM?

Tekla Life Sciences Investors (HQL) is growing the fastest with 23.6% revenue growth. JPMorgan Chase & Co. has the slowest growth at 14.6%. Higher growth often justifies higher valuations.

Which has the best profit margins: HQL or JPM?

Tekla Life Sciences Investors (HQL) has the strongest profitability with a 56.8% net margin. JPMorgan Chase & Co. has the lowest at 21.6%. Higher margins indicate pricing power and efficiency.

Which is the largest company: HQL or JPM?

JPMorgan Chase & Co. (JPM) is the largest company with a market cap of $833.8B. Tekla Life Sciences Investors is the smallest at $0.5B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: HQL or JPM?

JPMorgan Chase & Co. (JPM) generates the best returns on shareholder equity with an ROE of 17.4%. Tekla Life Sciences Investors has the lowest at 5.6%. Higher ROE indicates efficient use of capital.